Literature DB >> 21320123

Analyses of phenotypic and functional characteristics of CX3CR1-expressing natural killer cells.

Isabell Hamann1, Nadine Unterwalder, Astrid E Cardona, Christian Meisel, Frauke Zipp, Richard M Ransohoff, Carmen Infante-Duarte.   

Abstract

We previously demonstrated a correlation between the frequency of CX3CR1-expressing human natural killer (NK) cells and disease activity in multiple sclerosis and showed that CX3CR1(high) NK cells were more cytotoxic than their CX3CR1(neg/low) counterparts. Here we aimed to determine whether human NK cell fractions defined by CX3CR1 represent distinct subtypes. Phenotypic and functional NK cell analyses revealed that, distinct from CX3CR1(high), CX3CR1(neg/low) NK cells expressed high amounts of type 2 cytokines, proliferated robustly in response to interleukin-2 and promoted a strong up-regulation of the key co-stimulatory molecule CD40 on monocytes. Co-expression analyses of CX3CR1 and CD56 demonstrated the existence of different NK cell fractions based on the surface expression of these two surface markers, the CX3CR1(neg) CD56(bright), CX3CR1(neg) CD56(dim) and CX3CR1(high) CD56(dim) fractions. Additional investigations on the expression of NK cell receptors (KIR, NKG2A, NKp30 and NKp46) and the maturation markers CD27, CD62L and CD57 indicated that CX3CR1 expression of CD56(dim) discriminated between an intermediary CX3CR1(neg)  CD56(dim) and fully mature CX3CR1(high) CD56(dim) NK cell fractions. Hence, CX3CR1 emerges as an additional differentiation marker that may link NK cell maturation with the ability to migrate to different organs including the central nervous system.
© 2011 The Authors. Immunology © 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21320123      PMCID: PMC3088968          DOI: 10.1111/j.1365-2567.2011.03409.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  44 in total

1.  Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis.

Authors:  D H McDermott; J P Halcox; W H Schenke; M A Waclawiw; M N Merrell; N Epstein; A A Quyyumi; P M Murphy
Journal:  Circ Res       Date:  2001-08-31       Impact factor: 17.367

Review 2.  The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases.

Authors:  Frauke Zipp; Orhan Aktas
Journal:  Trends Neurosci       Date:  2006-08-01       Impact factor: 13.837

Review 3.  Natural killer cells in human autoimmunity.

Authors:  Malin Flodström-Tullberg; Yenan T Bryceson; Fu-Dong Shi; Petter Höglund; Hans-Gustaf Ljunggren
Journal:  Curr Opin Immunol       Date:  2009-11-04       Impact factor: 7.486

4.  Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis.

Authors:  Cristina Cerboni; Alessandra Zingoni; Marco Cippitelli; Mario Piccoli; Luigi Frati; Angela Santoni
Journal:  Blood       Date:  2007-04-03       Impact factor: 22.113

Review 5.  Fractalkine in rheumatoid arthritis and allied conditions.

Authors:  Hisanori Umehara; Masao Tanaka; Toshioki Sawaki; Zhe-Xiong Jin; Cheng-Ri Huang; Lingli Dong; Takafumi Kawanami; Hiromi Karasawa; Yasufumi Masaki; Toshihiro Fukushima; Yuko Hirose; Toshirou Okazaki
Journal:  Mod Rheumatol       Date:  2006       Impact factor: 3.023

6.  Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education.

Authors:  Niklas K Björkström; Peggy Riese; Frank Heuts; Sandra Andersson; Cyril Fauriat; Martin A Ivarsson; Andreas T Björklund; Malin Flodström-Tullberg; Jakob Michaëlsson; Martin E Rottenberg; Carlos A Guzmán; Hans-Gustaf Ljunggren; Karl-Johan Malmberg
Journal:  Blood       Date:  2010-08-09       Impact factor: 22.113

7.  Fractalkine induces chemotaxis and actin polymerization in human dendritic cells.

Authors:  S Dichmann; Y Herouy; D Purlis; H Rheinen; P Gebicke-Härter; J Norgauer
Journal:  Inflamm Res       Date:  2001-11       Impact factor: 4.575

8.  Differentiation of human NK cells into NK1 and NK2 subsets.

Authors:  D Peritt; S Robertson; G Gri; L Showe; M Aste-Amezaga; G Trinchieri
Journal:  J Immunol       Date:  1998-12-01       Impact factor: 5.422

9.  Natural killer cells trigger differentiation of monocytes into dendritic cells.

Authors:  Angela L Zhang; Paula Colmenero; Ulrich Purath; Cristina Teixeira de Matos; Wolfgang Hueber; Lars Klareskog; Ingo H Tarner; Edgar G Engleman; Kalle Söderström
Journal:  Blood       Date:  2007-07-12       Impact factor: 22.113

10.  CD27 defines phenotypically and functionally different human NK cell subsets.

Authors:  Mireille T M Vossen; Mourad Matmati; Kirsten M L Hertoghs; Paul A Baars; Mi-Ran Gent; Georges Leclercq; Jörg Hamann; Taco W Kuijpers; René A W van Lier
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

View more
  30 in total

Review 1.  Natural killer cells and their receptors in multiple sclerosis.

Authors:  Gurman Kaur; John Trowsdale; Lars Fugger
Journal:  Brain       Date:  2012-06-25       Impact factor: 13.501

2.  In vivo structure/function and expression analysis of the CX3C chemokine fractalkine.

Authors:  Ki-Wook Kim; Alexandra Vallon-Eberhard; Ehud Zigmond; Julia Farache; Elias Shezen; Guy Shakhar; Andreas Ludwig; Sergio A Lira; Steffen Jung
Journal:  Blood       Date:  2011-09-27       Impact factor: 22.113

Review 3.  NK cell trafficking in health and autoimmunity:a comprehensive review.

Authors:  Hui Peng; Zhigang Tian
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

4.  CX3CR1-dependent recruitment of mature NK cells into the central nervous system contributes to control autoimmune neuroinflammation.

Authors:  Laura Hertwig; Isabell Hamann; Silvina Romero-Suarez; Jason M Millward; Rebekka Pietrek; Coralie Chanvillard; Hanna Stuis; Karolin Pollok; Richard M Ransohoff; Astrid E Cardona; Carmen Infante-Duarte
Journal:  Eur J Immunol       Date:  2016-07-14       Impact factor: 5.532

5.  Effect of chemokine receptor CX3CR1 deficiency in a murine model of respiratory syncytial virus infection.

Authors:  Crystal H Johnson; Congrong Miao; Elisabeth G Blanchard; Hayat Caidi; Gertrud U Radu; Jennifer L Harcourt; Lia M Haynes
Journal:  Comp Med       Date:  2012-02       Impact factor: 0.982

Review 6.  NK cells: immune cross-talk and therapeutic implications.

Authors:  Anshu Malhotra; Anil Shanker
Journal:  Immunotherapy       Date:  2011-10       Impact factor: 4.196

Review 7.  Macrophages at CNS interfaces: ontogeny and function in health and disease.

Authors:  Katrin Kierdorf; Takahiro Masuda; Marta Joana Costa Jordão; Marco Prinz
Journal:  Nat Rev Neurosci       Date:  2019-07-29       Impact factor: 34.870

Review 8.  Organ-specific features of natural killer cells.

Authors:  Fu-Dong Shi; Hans-Gustaf Ljunggren; Antonio La Cava; Luc Van Kaer
Journal:  Nat Rev Immunol       Date:  2011-09-23       Impact factor: 53.106

9.  The role of natural killer cells in multiple sclerosis and their therapeutic implications.

Authors:  Coralie Chanvillard; Raymond F Jacolik; Carmen Infante-Duarte; Ramesh C Nayak
Journal:  Front Immunol       Date:  2013-03-13       Impact factor: 7.561

10.  Fractalkine aggravates LPS-induced macrophage activation and acute kidney injury via Wnt/β-catenin signalling pathway.

Authors:  Qiming Gong; Yan Jiang; Xiuhong Pan; Yanwu You
Journal:  J Cell Mol Med       Date:  2021-06-07       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.